Viewing Study NCT02640157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT02640157
Status: COMPLETED
Last Update Posted: 2021-07-30
First Post: 2015-12-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
None Hepatitis C Virus View
None Genotype 3 Hepatitis C Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None interferon free View
None Hepatitis C View
None daclatasvir View
None Sovaldi View
None HCV View
None Hepatitis C Virus View
None Hepatitis C Genotype 3 View
None Hep C View
None sofosbuvir View
None Chronic Hepatitis C View
None Daklinza View